Home›People›Hugo Beekman
HB

Hugo Beekman

Director at EvolveImmune Therapeutics Holding Company.

Director
Updated Nov 15, 2026·Latest SEC filing Jan 17, 2020·Suggest an edit

About Hugo Beekman

Form D filings for EvolveImmune Therapeutics Holding Company in 2020 list Hugo Beekman as director.

Hugo Beekman first appears on SEC filings in 2020.

Experience

This experience comes from SEC filings. The years are when the filings name Hugo Beekman in the role, so the role may have started earlier or lasted longer.

EvolveImmune Therapeutics Holding Company, LLC
Director
2020 · Branford, CT
Develops immune-based cancer treatments for patients with solid tumors and blood cancers.

Key Colleagues at Startups

The people Hugo Beekman works with at each company, as listed on that company's latest Form D.

SB
Stephen Bloch
Co-founder and Chief Executive Officer
DP

Sources

  1. SECEvolveImmune Therapeutics Holding Company, LLC Form D, filed Jan 17, 2020